We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.76%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$82.7B
AUM Growth
+$473M
(+0.58%)
Cap. Flow
+$823M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
14.9%
Holding
783
New
76
Increased
301
Reduced
323
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$598M |
| 2 |
Apollo Global Management
APO
|
+$418M |
| 3 |
Allstate
ALL
|
+$416M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$385M |
| 5 |
Quest Diagnostics
DGX
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$431M |
| 2 |
Delta Air Lines
DAL
|
+$318M |
| 3 |
Deere & Co
DE
|
+$282M |
| 4 |
Robert Half
RHI
|
+$270M |
| 5 |
Curtiss-Wright
CW
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.07% |
| 2 | Technology | 14.6% |
| 3 | Industrials | 13.72% |
| 4 | Healthcare | 11.92% |
| 5 | Consumer Discretionary | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Rexford Industrial Realty
REXR
$8.63B
| $2.64M | ﹤0.01% |
67,392
-3,092,880
| -98% | -$124M |
|
477
Yext
YEXT
$573M
| $2.59M | ﹤0.01% |
420,527
-14,553
| -3% | -$94.1K |
|
478
First Mid Bancshares
FMBH
$1.4B
| $2.57M | ﹤0.01% |
73,668
-2,579
| -3% | -$95.2K |
|
|
GTY
479
Getty Realty Corp
GTY
$2.16B
| $2.55M | ﹤0.01% |
81,668
+12,754
| +19% | +$391K |
|
480
British American Tobacco
BTI
$136B
| $2.54M | ﹤0.01% |
61,443
+3,856
| +7% | +$152K |
|
481
Hanover Insurance
THG
$8.13B
| $2.51M | ﹤0.01% |
14,450
+445
| +3% | +$72K |
|
482
Northrim BanCorp
NRIM
$593M
| $2.47M | ﹤0.01% |
+135,144
| New | +$2.68M |
|
483
Enterprise Financial Services Corp
EFSC
$2.4B
| $2.4M | ﹤0.01% |
44,649
+1,374
| +3% | +$79.1K |
|
484
Vistra
VST
$48.2B
| $2.35M | ﹤0.01% |
+20,043
| New | +$2.99M |
|
485
Barrett Business Services
BBSI
$1.01B
| $2.19M | ﹤0.01% |
53,183
+1,291
| +2% | +$53.8K |
|
486
Myers Industries
MYE
$1.24B
| $2.16M | ﹤0.01% |
180,779
-6,294
| -3% | -$74.3K |
|
487
Build-A-Bear
BBW
$445M
| $2.15M | ﹤0.01% |
57,924
-2,036
| -3% | -$80.9K |
|
488
James River Group Holdings
JRVR
$219M
| $2.15M | ﹤0.01% |
511,616
-17,792
| -3% | -$80.8K |
|
489
Canadian Pacific Kansas City
CP
$81B
| $2.13M | ﹤0.01% |
+30,306
| New | +$2.31M |
|
490
Upwork
UPWK
$1.18B
| $2.12M | ﹤0.01% |
+162,278
| New | +$2.47M |
|
491
M&T Bank
MTB
$36.3B
| $2.07M | ﹤0.01% |
+11,582
| New | +$2.2M |
|
492
Arcos Dorados Holdings
ARCO
$1.74B
| $2.05M | ﹤0.01% |
254,519
+26,232
| +11% | +$207K |
|
493
Celestica
CLS
$37.8B
| $2.01M | ﹤0.01% |
25,555
-5,769
| -18% | -$612K |
|
494
Scorpio Tankers
STNG
$3.91B
| $2M | ﹤0.01% |
53,177
+6,229
| +13% | +$279K |
|
495
Spire
SR
$4.79B
| $1.98M | ﹤0.01% |
25,334
-6,179
| -20% | -$452K |
|
496
Biote Corp
BTMD
$61.9M
| $1.97M | ﹤0.01% |
591,040
-15,063
| -2% | -$71.8K |
|
497
Takeda Pharmaceutical
TAK
$56.7B
| $1.96M | ﹤0.01% |
132,107
+63,024
| +91% | +$883K |
|
498
Star Bulk Carriers
SBLK
$3.05B
| $1.95M | ﹤0.01% |
125,368
-33,516
| -21% | -$523K |
|
499
American Homes 4 Rent
AMH
$12.1B
| $1.94M | ﹤0.01% |
+51,272
| New | +$1.83M |
|
500
Asure Software
ASUR
$242M
| $1.93M | ﹤0.01% |
202,008
-7,000
| -3% | -$76.7K |
|
Similar funds
Boston Partners's Q1 2025 Portfolio in Review
As of Q1 2025, Boston Partners held 783 positions worth $82.7B, up 0.58% from $82.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q1 2025 filing shows 76 new, 301 increased, 323 reduced and 81 closed positions. Its largest new stake was Coca-Cola: 8,951,766 shares worth $642M. The largest sale was Amgen, an estimated $431M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.
- Boston Partners's largest Q1 2025 buy was Coca-Cola: 8,951,766 shares worth $642M.
- Boston Partners added most to Allstate in Q1 2025, an estimated $416M increase.
- Boston Partners's biggest Q1 2025 reduction was Amgen, cutting an estimated $431M.
- Boston Partners fully exited Hologic in Q1 2025, selling an estimated $258M.
- Boston Partners's ten largest holdings make up 15% of its $82.7B portfolio in Q1 2025.
- Boston Partners opened 76 new positions and closed 81 in Q1 2025.
- Boston Partners's portfolio value rose 0.58% quarter-over-quarter to $82.7B.
Based on Boston Partners's 13F filing for Q1 2025, filed 13 May 2025.